Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG
- PMID: 24862877
- DOI: 10.1007/s40618-014-0077-6
Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG
Abstract
Purpose: Despite international guidelines being available, not all gender clinics are able to face gender dysphoric (GD) youth population needs specifically. This is particularly true in Italy. Centers offering specialized support are relatively few and a commonly accepted Italian approach to GD youth has still not been defined. The aim of the present Position Statement is to develop and adhere to Italian guidelines for treatment of GD adolescents, in line with the "Dutch Approach", the Endocrine Society (ES), and the World Professional Association for Transgender Health (WPATH) guidelines.
Methods: An in-depth brainstorming on the application of International guidelines in the Italian context was performed by several dedicated professionals.
Results: A staged approach, combining psychological support as well as medical intervention is suggested. In the first phase, individuals requesting medical help will undergo a psycho-diagnostic procedure to assess GD; for eligible adolescents, pubertal suppression should be made available (extended diagnostic phase). Finally, from the age of 16 years, cross-sex hormonal therapy can be added, and from the age of 18 years, surgical sex reassignment can eventually be performed.
Conclusions: The current inadequacy of Italian services offering specialized support for GD youth may lead to negative consequences. Omitting or delaying treatment is not a neutral option. In fact, some GD adolescents may develop psychiatric problems, suicidality, and social marginalization. With access to specialized GD services, emotional problems, as well as self-harming behavior, may decrease and general functioning may significantly improve. In particular, puberty suppression seems to be beneficial for GD adolescents by relieving their acute suffering and distress and thus improving their quality of life.
Similar articles
-
Young adult psychological outcome after puberty suppression and gender reassignment.Pediatrics. 2014 Oct;134(4):696-704. doi: 10.1542/peds.2013-2958. Epub 2014 Sep 8. Pediatrics. 2014. PMID: 25201798
-
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.J Sex Med. 2015 Nov;12(11):2206-14. doi: 10.1111/jsm.13034. Epub 2015 Nov 9. J Sex Med. 2015. PMID: 26556015
-
Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.J Endocrinol Invest. 2019 Oct;42(10):1231-1240. doi: 10.1007/s40618-019-01045-2. Epub 2019 Apr 5. J Endocrinol Invest. 2019. PMID: 30953318
-
Clinical management of gender dysphoria in children and adolescents: the Dutch approach.J Homosex. 2012;59(3):301-20. doi: 10.1080/00918369.2012.653300. J Homosex. 2012. PMID: 22455322 Review.
-
Management of juvenile gender dysphoria.Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):559-64. doi: 10.1097/01.med.0000436193.33470.1f. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 24468758 Review.
Cited by
-
Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.J Endocrinol Invest. 2016 Nov;39(11):1207-1224. doi: 10.1007/s40618-016-0482-0. Epub 2016 Jun 10. J Endocrinol Invest. 2016. PMID: 27287420 Review.
-
Cross-cultural and socio-demographic correlates of homophobic attitude among university students in three European countries.J Endocrinol Invest. 2017 Feb;40(2):227-233. doi: 10.1007/s40618-016-0554-1. Epub 2016 Sep 25. J Endocrinol Invest. 2017. PMID: 27667822
-
Is puberty delaying treatment 'experimental treatment'?Int J Transgend Health. 2020 Apr 11;21(2):113-121. doi: 10.1080/26895269.2020.1747768. eCollection 2020. Int J Transgend Health. 2020. PMID: 33015663 Free PMC article. No abstract available.
-
Quality of life and hormones after sex reassignment surgery.J Endocrinol Invest. 2015 Dec;38(12):1373-81. doi: 10.1007/s40618-015-0398-0. J Endocrinol Invest. 2015. PMID: 26486135
-
A Critical Review of Clinical Practice Guidelines for Care of Transgender and Gender Diverse Children and Youth for Use by Primary Care Practitioners.Transgend Health. 2022 Oct 7;7(5):397-406. doi: 10.1089/trgh.2020.0185. eCollection 2022 Oct. Transgend Health. 2022. PMID: 36644485 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical